Nyxoah Stock Fundamentals
| NYXH Stock | USD 8.20 0.20 2.50% |
Nyxoah fundamentals help investors to digest information that contributes to Nyxoah's financial success or failures. It also enables traders to predict the movement of Nyxoah Stock. The fundamental analysis module provides a way to measure Nyxoah's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nyxoah stock.
As of now, Nyxoah's Total Revenue is increasing as compared to previous years. The Nyxoah's current Gross Profit is estimated to increase to about 2.8 M, while Tax Provision is forecasted to increase to (312.6 K). Nyxoah | Select Account or Indicator |
Nyxoah Company Return On Equity Analysis
Nyxoah's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nyxoah Return On Equity | -0.5 |
Most of Nyxoah's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nyxoah is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Nyxoah Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Nyxoah has a Return On Equity of -0.4969. This is 97.93% lower than that of the Health Care Equipment & Supplies sector and 91.69% lower than that of the Health Care industry. The return on equity for all United States stocks is 60.29% higher than that of the company.
Nyxoah Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nyxoah's current stock value. Our valuation model uses many indicators to compare Nyxoah value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nyxoah competition to find correlations between indicators driving Nyxoah's intrinsic value. More Info.Nyxoah is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, Nyxoah's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nyxoah's earnings, one of the primary drivers of an investment's value.Nyxoah Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nyxoah's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nyxoah could also be used in its relative valuation, which is a method of valuing Nyxoah by comparing valuation metrics of similar companies.Nyxoah is currently under evaluation in return on equity category among its peers.
Nyxoah ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Nyxoah's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Nyxoah's managers, analysts, and investors.Environmental | Governance | Social |
Nyxoah Fundamentals
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.23 | ||||
| Operating Margin | (11.83) % | ||||
| Current Valuation | 264.81 M | ||||
| Shares Outstanding | 37.39 M | ||||
| Shares Owned By Insiders | 43.75 % | ||||
| Shares Owned By Institutions | 28.20 % | ||||
| Number Of Shares Shorted | 58.83 K | ||||
| Price To Book | 2.73 X | ||||
| Price To Sales | 61.29 X | ||||
| Revenue | 4.35 M | ||||
| Gross Profit | 1.93 M | ||||
| EBITDA | (43.29 M) | ||||
| Net Income | (44.66 M) | ||||
| Cash And Equivalents | 123.32 M | ||||
| Cash Per Share | 4.77 X | ||||
| Total Debt | 12.7 M | ||||
| Debt To Equity | 0.09 % | ||||
| Current Ratio | 7.24 X | ||||
| Book Value Per Share | 3.04 X | ||||
| Cash Flow From Operations | (44.78 M) | ||||
| Short Ratio | 0.41 X | ||||
| Earnings Per Share | (1.81) X | ||||
| Target Price | 14.91 | ||||
| Number Of Employees | 146 | ||||
| Beta | 0.55 | ||||
| Market Capitalization | 311.49 M | ||||
| Total Asset | 124.16 M | ||||
| Retained Earnings | (160.83 M) | ||||
| Working Capital | 53.91 M | ||||
| Net Asset | 124.16 M |
About Nyxoah Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nyxoah's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nyxoah using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nyxoah based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 1.8 M | 3.1 M | |
| Total Revenue | 4.3 M | 4.6 M | |
| Cost Of Revenue | 1.7 M | 937.7 K | |
| Stock Based Compensation To Revenue | 0.60 | 0.57 | |
| Sales General And Administrative To Revenue | 4.75 | 4.51 | |
| Research And Ddevelopement To Revenue | 6.36 | 6.04 | |
| Capex To Revenue | 2.52 | 2.40 | |
| Revenue Per Share | 0.16 | 0.16 | |
| Ebit Per Revenue | (10.37) | (10.89) |
Currently Active Assets on Macroaxis
When determining whether Nyxoah offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nyxoah's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nyxoah Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nyxoah Stock:Check out Nyxoah Piotroski F Score and Nyxoah Altman Z Score analysis. For more detail on how to invest in Nyxoah Stock please use our How to Invest in Nyxoah guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nyxoah. If investors know Nyxoah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nyxoah listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.81) | Revenue Per Share 0.166 | Quarterly Revenue Growth 0.297 | Return On Assets (0.23) | Return On Equity (0.50) |
The market value of Nyxoah is measured differently than its book value, which is the value of Nyxoah that is recorded on the company's balance sheet. Investors also form their own opinion of Nyxoah's value that differs from its market value or its book value, called intrinsic value, which is Nyxoah's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nyxoah's market value can be influenced by many factors that don't directly affect Nyxoah's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nyxoah's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nyxoah is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nyxoah's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.